Literature DB >> 7540642

Monocytes cultured in cytokine-defined environments differ from freshly isolated monocytes in their responses to IL-4 and IL-10.

P H Hart1, C A Jones, J J Finlay-Jones.   

Abstract

To investigate the regulatory effects of the prototypic Th2 lymphocyte products and potential immunotherapeutic agents interleukin-4 (IL-4) and IL-10 on macrophages differentiated in vitro under different cytokine-defined environments, blood monocytes were incubated for 7 days in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF), macrophage colony-stimulating factor or IL-4. The effect of monocyte culture in the presence or absence of serum was also investigated. Functional responses by 7-day-cultured cells to IL-4, quantified as decreased CD14 expression and suppression of lipopolysaccharide (LPS)-induced tumor necrosis factor-alpha (TNF-alpha) and IL-1 beta production, and as a positive response, increased CD23 expression, were compared directly with the responses by monocytes from which they were derived. In response to IL-10, decreases in LPS-induced TNF-alpha and IL-1 beta production and reduction in the expression of major histocompatibility complex (MHC) class II antigens were examined. Seven-day cultured monocytes/macrophages showed (1) diminished TNF-alpha production in response to IL-10 but not IL-4 (2), diminished IL-1 beta production in response to both IL-4 and IL-10, and compared with fresh monocytes (3), diminished CD14 expression in response to IL-4, and (4) a lesser increase in CD23 expression in response to IL-4. This was the case regardless of the cytokine in the presence of which the cells had been cultured for 7 days. Monocytes cultured for 7 days in GM-CSF expressed increased levels of MHC class II and LPS-induced TNF-alpha and responded inefficiently to IL-10 for decreased MHC class II. The responses by monocytes cultured for 7 days with GM-CSF resemble the published properties of synovial fluid macrophages from patients with chronic inflammatory arthritis. The study highlights the complexity of monocyte/macrophage responses to the immunoregulatory cytokines IL-4 and IL-10 and concludes that responses to IL-4 and IL-10 by blood monocytes may not be representative of responses by their differentiated or activated counterparts.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7540642     DOI: 10.1002/jlb.57.6.909

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  11 in total

1.  Granulocyte-macrophage colony-stimulating factor modulates lipopolysaccharide (LPS)-binding and LPS-response of human macrophages: inverse regulation of tumour necrosis factor-alpha and interleukin-10.

Authors:  M Kreutz; B Hennemann; U Ackermann; E Grage-Griebenow; S W Krause; R Andreesen
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

2.  Synergistic effect of immunoregulatory cytokines on peripheral blood monocytes from patients with inflammatory bowel disease.

Authors:  T Kucharzik; N Lügering; M Adolf; W Domschke; R Stoll
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

3.  Control of major histocompatibility complex class II expression on human monocytes by interleukin-4: regulatory effect of lipopolysaccharide.

Authors:  P H Hart; C S Bonder; C A Jones; J J Finlay-Jones
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

Review 4.  Macrophage phenotypes during tissue repair.

Authors:  Margaret L Novak; Timothy J Koh
Journal:  J Leukoc Biol       Date:  2013-03-15       Impact factor: 4.962

5.  Macrophages from inflamed but not normal glomeruli are unresponsive to anti-inflammatory cytokines.

Authors:  L P Erwig; K Stewart; A J Rees
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

6.  Contribution of Reduced Interleukin-10 Levels to the Pathogenesis of Osteomyelitis in Children with Sickle Cell Disease.

Authors:  Sameh Sarray; Wassim Y Almawi
Journal:  Clin Vaccine Immunol       Date:  2015-07-01

7.  Interleukin-4 regulation of human monocyte and macrophage interleukin-10 and interleukin-12 production. Role of a functional interleukin-2 receptor gamma-chain.

Authors:  C S Bonder; J J Finlay-Jones; P H Hart
Journal:  Immunology       Date:  1999-04       Impact factor: 7.397

8.  Interleukin-10 gene therapy-mediated amelioration of bacterial pneumonia.

Authors:  D F Morrison; D L Foss; M P Murtaugh
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

9.  The anti-inflammatory effects of interleukin-4 are not mediated by suppressor of cytokine signalling-1 (SOCS1).

Authors:  Eleanor A Woodward; Cecilia M Prêle; Sandra E Nicholson; Tatiana B Kolesnik; Prue H Hart
Journal:  Immunology       Date:  2010-04-06       Impact factor: 7.397

10.  Granulocyte-macrophage colony-stimulating factor regulates cytokine production in cultured macrophages through CD14-dependent and -independent mechanisms.

Authors:  A Bergamini; F Bolacchi; B Bongiovanni; M Cepparulo; L Ventura; M Capozzi; C Sarrecchia; G Rocchi
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.